Literature DB >> 18188494

The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats.

W Kolasiewicz1, J Maj, K Ossowska.   

Abstract

A preferential agonist of dopamine D3 receptors, 7-hydroxy-N-N-di-n-propyl-2-aminotetralin (7-OH-DPAT), injected into the cerebellar lobules 9 and 10 (0.001-10 microg/0.5 microl) dose-dependently reduced locomotor activity of rats. 7-OH-DPAT injections into the lobule 8 were ineffective. The 7-OH-DPAT-induced hypolocomotion was inhibited by intracerebellar (0.9 microg/0.5 microl) or systemic (0.2 mg/kg sc) injection of a selective D3 receptor antagonist, (3aR,9bS)-N-[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl]-(4-phenyl) benzamide (S33084). The present results indicate that dopamine D3 receptors in lobules 9 and 10 contribute to 7-OH-DPAT-induced hypolocomotion.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18188494     DOI： 10.1007/s00702-007-0009-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  26 in total

1.  Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex.

Authors:  P Barili; E Bronzetti; A Ricci; D Zaccheo; F Amenta
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

2.  Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.

Authors:  W Kolasiewicz; J Maj
Journal:  Pol J Pharmacol       Date:  2001 Sep-Oct

3.  Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.

Authors:  Samir Barik; Renaud de Beaurepaire
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-06       Impact factor: 5.067

4.  The anatomy of the cerebellum.

Authors:  J Voogd; M Glickstein
Journal:  Trends Cogn Sci       Date:  1998-09-01       Impact factor: 20.229

5.  Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.

Authors:  J Diaz; C Pilon; B Le Foll; C Gros; A Triller; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation.

Authors:  D S Melchitzky; D A Lewis
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

7.  S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

Authors:  M J Millan; A Gobert; A Newman-Tancredi; F Lejeune; D Cussac; J M Rivet; V Audinot; T Dubuffet; G Lavielle
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Dopaminergic innervation and binding in the rat cerebellum.

Authors:  N T Panagopoulos; G C Papadopoulos; N A Matsokis
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

9.  The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway.

Authors:  J S Kizer; M Palkovits; M J Brownstein
Journal:  Brain Res       Date:  1976-05-28       Impact factor: 3.252

10.  Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.

Authors:  Michael J Hurley; Deborah C Mash; Peter Jenner
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386
View more
  6 in total

1.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

Review 2.  Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.

Authors:  Bernard Le Foll; Patricia Di Ciano
Journal:  Eur Neuropsychopharmacol       Date:  2014-09-16       Impact factor: 4.600

3.  Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor.

Authors:  Masaki Kato; Naofumi Kunisawa; Saki Shimizu; Higor A Iha; Yukihiro Ohno
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

4.  Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine.

Authors:  Brian C Nolan; Shinban Liu; Lindsey R Hammerslag; Timothy H C Cheung; Jeffrey Lenz; Robert H Mach; Robert R Luedtke; Janet L Neisewander
Journal:  Synapse       Date:  2013-07-17       Impact factor: 2.562

5.  The Effects of Intravermis Cerebellar Microinjections of Dopaminergic Agents in Motor Learning and Aversive Memory Acquisition in Mice.

Authors:  Evelyn M Guilherme; Anna Carolyna L Gianlorenço
Journal:  Front Behav Neurosci       Date:  2021-02-25       Impact factor: 3.558

Review 6.  The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models.

Authors:  Barbara Kosmowska; Jadwiga Wardas
Journal:  Biomolecules       Date:  2021-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.